Imagen de perfil
I am also in it and have written a text about it
2
Imagen de perfil
@topicswithhead yes, I even saw it 😎 but I actually only became aware of the share because the finchat screener "spit it out" 😁
Imagen de perfil
@Dirty30 is a great share, anyone who is interested in biotech should get in. The share is falling, sales and pipeline are rising, etc.
1
Imagen de perfil
@topicswithhead which is actually the best case scenario :D So I'm also curious to see how long this will continue to run contrary to the original.
Imagen de perfil
@Dirty30 but in the end I don't really care. If it were to fall below 200 again, that would be a great buy.